Publicações

Gene Expression Analysis of Paired Baseline (Bl) and On-Treatment Tumor Samples from Fairlane, a Double-Blind Placebo (Pbo)-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib (Ipat) plus Paclitaxel (Pac) in Early Triple-Negative Breast Cancer (Etnbc)

AuthID
P-00R-5Y3

Author(s)

Shi, Z

Isakoff, SJ

Saura, C

Nuciforo, P

Calvo, I

Andersen, J

Passos Coelho, JLP

Gil Gil, MG

Bermejo, B

Patt, DA

Ciruelos, E

Wongchenko, MJ

Singel, SM

Xu, N

de la Pena, L

Baselga, J

Gendreau, S

Oliveira, M

Tipo de Documento

Abstract

Year published

2019

Publicado

in CANCER RESEARCH, ISSN: 0008-5472

Volume: 79, Número: 13

Conference

Annual Meeting of the American-Association-For-Cancer-Research (Aacr), Date: MAR 29-APR 03, 2019, Location: Atlanta, GA, Patrocinadores: Amer Assoc Canc Res

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1158/1538-7445.am2019-4891

Wos: WOS:000488279405248

Source Identifiers

ISSN: 0008-5472

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Gene Expression Analysis of Paired Baseline (Bl) and On-Treatment Tumor Samples from Fairlane, a Double-Blind Placebo (Pbo)-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib (Ipat) plus Paclitaxel (Pac) in Early Triple-Negative Breast Cancer (Etnbc)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Gene Expression Analysis of Paired Baseline (Bl) and On-Treatment Tumor Samples from Fairlane, a Double-Blind Placebo (Pbo)-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib (Ipat) plus Paclitaxel (Pac) in Early Triple-Negative Breast Cancer (Etnbc)

Links Úteis

Ajuda